ChangChun High New Technology Industries operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ChangChun High New Technology Industries with three other
companies in this sector in China:
Shanxi Zhendong Pharmaceutical Co Ltd
sales of 3.73 billion Chinese Renmimbi [US$544.93 million]
of which 101%
was Medicine Manufacture and Sale),
Shandong Xinhua Pharmaceutical Company Limited
(4.52 billion Chinese Renmimbi [US$659.43 million]
of which 44%
was Preparations), and
Tianjin Chase Sun Pharmaceutical Company Limited
(3.37 billion Chinese Renmimbi [US$492.70 million]
of which 52%
During the year ended December of 2017, sales at
ChangChun High New Technology Industries were 4.04 billion Chinese Renmimbi (US$589.87 million).
increase of 40.6%
versus 2016, when the company's sales were 2.87 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at ChangChun High New Technology Industries
(and since 2012, sales have increased a total of 132%).
Sales of Medication saw an increase
48.3% in 2017, from
2.32 billion Chinese Renmimbi to 3.44 billion Chinese Renmimbi.